Effects of Doubling the Highest Indicated Dose of Budesonide/Formoterol (BUD/FM) on Lung Function and Symptoms in Moderate-to-Severe Asthma with Fixed Airflow Obstruction (FAO)

Rationale To assess whether doubling the highest indicated BUD/FM dose additionally benefits lung function and symptoms in moderate-to-severe asthmatic patients with FAO.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2015-02, Vol.135 (2), p.AB4-AB4
Main Authors: DePietro, Michael, MD, Tashkin, Donald P., MD, Chipps, Bradley E., MD, FAAAAI, Trudo, Frank, MD
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Drug therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale To assess whether doubling the highest indicated BUD/FM dose additionally benefits lung function and symptoms in moderate-to-severe asthmatic patients with FAO.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.12.949